LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Farms & Vineyards for Sale
Grocery Stores & Delis for Sale
Manufacturing Businesses for Sale
Employment & Personnel Businesses for Sale
Healthcare & Medical Businesses for Sale
Startup Investment Opportunities
Travel Businesses for Sale
Consulting & Training Businesses for Sale
Clothing & Shoe Stores for Sale
Printing, Signs & Publishing Businesses for Sale
Gift & Flower Shop Franchise Opportunities
Miscellaneous Franchises for Sale
Senior Care Franchise for Sale
Finance & Accounting Franchise Opportunities
Consultancy & Training Franchise Opportunities
Technology Franchise Opportunities
Transport & Shipping Franchise Opportunities
Post Office Franchises for Sale
Smoke & Vape Shop Franchises for Sale
Real Estate & Property Management Franchise for Sale
Medical Buildings for Sale or Lease
Mixed Use Buildings for Sale or Rent
Office Buildings for Sale or Rent
Miscellaneous Properties for Sale or Lease
Land & Developments for Sale
Commercial Buildings for Sale or Lease
Places of Worship for Sale
Medical Office Spaces for Sale or Rent
Retail Buildings for Sale or Lease
Retail Spaces for Lease or Sale
An email will be sent to registered email address.
Please select if you are: